Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced liver disease

R T Holzbach

    Primary Care
    |June 1, 1981
    PubMed
    Summary

    Drug-induced liver disease arises from factors like drug metabolism via cytochrome P-450, toxic metabolite formation, and glutathione levels. Genetic predispositions may also influence susceptibility to liver damage.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Apolipoprotein A-I in bile inhibits cholesterol crystallization and modifies transcellular lipid transfer through cultured human gall-bladder epithelial cells.

    Journal of gastroenterology and hepatology·1999
    Same author

    Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.

    Digestive diseases and sciences·1998
    Same author

    Variations in pigment and carbohydrate content of gallbladder bile affect accurate quantitation of total protein when using the fluorescamine method.

    Scandinavian journal of gastroenterology·1997
    Same author

    [Role of biliary proteins in pathogenesis of cholesterol gallstones].

    Zeitschrift fur Gastroenterologie·1997
    Same author

    Newer pathogenetic concepts in cholesterol gallstone formation: a unitary hypothesis.

    Digestion·1997
    Same author

    Comparison of haptoglobin and apolipoprotein A-I on biliary lipid particles involved in cholesterol crystallization.

    Journal of gastroenterology and hepatology·1996

    Area of Science:

    • Hepatology
    • Toxicology
    • Pharmacology

    Background:

    • Drug-induced liver disease (DILD) is a significant clinical concern.
    • Its pathogenesis involves complex interactions between xenobiotics and host factors.

    Purpose of the Study:

    • To elucidate the multifactorial mechanisms underlying drug-induced liver injury.
    • To identify key determinants of DILD susceptibility and severity.

    Main Methods:

    • Review of established biochemical and genetic pathways involved in drug metabolism.
    • Analysis of the role of hepatic microsomal enzymes, particularly cytochrome P-450.
    • Examination of the impact of glutathione levels and genetic polymorphisms on drug toxicity.

    Main Results:

    • Drug metabolism by hepatic microsomal mixed-function oxidase (MFO) enzymes, including cytochrome P-450, is a primary factor.
    • Formation of activated, toxic metabolites during drug biotransformation is crucial for DILD.
    • Glutathione depletion can lead to irreversible hepatocyte necrosis.
    • Genetic factors, such as rapid acetylation, may predispose individuals to DILD.

    Conclusions:

    • DILD pathogenesis is multifactorial, involving drug metabolism, metabolite reactivity, and host defense mechanisms.
    • Understanding these factors is essential for predicting and preventing drug-induced liver injury.
    • Further research into genetic abnormalities in drug metabolism may reveal additional DILD pathways.

    Related Experiment Videos